|
Methylphenidate in Male Rhesus Monkeys
|
Research Initiative
|
FDA
|
NICHD
|
The purpose of this IAA is to utilize a structure approach to evaluate the safety of this frequently used stimulant in a developing animal model in accordance with FDA protocol E0728701. The information from these experiences will enhance our ability to conduct a safety assessment of methylphenidate in humans.
|
|
mHealth (Mobile Health Technologies) Evidence meeting
|
Meeting/ Workshop
|
CMS, FDA, HRSA
|
OD, NHLBI, NICHD
|
Meeting designed to identify methodology to enhance mobile health (mHealth) research. The meeting brought together experts from the research, public and private sectors to address the methods in this area. Enhancing utilization of mobile technology should have a significant public health impact.
|
|
mHealth (Mobile Health Technologies) Summit 2011
|
Meeting/ Workshop
|
FDA, OS, OSG
|
OD, FIC, NCI, NHLBI, NIBIB, NICHD, NIDA, NIDDK, NIEHS, NINDS, NLM
|
Multi-sector meeting on mHealth technology, services, research, utilization and policy; convened by FNIH with multiple partners. NIH contributions included abstract solicitation and review, organizing research sessions and networking meetings around specific topics, and interactions with stakeholders representing foundations, NGOs, industry and academia.
|
|
Microbicide Trials Network Executive Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
OD/DPCPSI/OAR, NIAID, NICHD, NIMH, OD
|
A committee designed to make strategic decisions and prioritize research for the MTN
|
|
Microsystems Team
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDDK, NINDS, OD
|
The NIH has identified a critical need for improved model systems to predict efficacy, safety, bioavailability, and toxicology outcomes for candidate therapeutics. This NIH FOA, supported by funds from the NIH Common Fund and participating NIH IC''s, invites applications for projects that will develop accurate cellular and organ microsystems representative of human physiology for the evaluation of drug efficacy and toxicity. By definition, these cellular and organ microsystems will have a multicellular architecture representing the characteristics and functions of the tissue of origin and will demonstrate a reproducible and viable operation under physiological conditions over a long culture period. It is anticipated that these bio-engineered human tissue models could lead to the development and commercialization of microsystems that will enable rapid and high fidelity evaluation of safety and efficacy for candidate therapeutics.
|
|
Million Hearts
|
Committee, Work group, Advisory group, or Task Force
|
AoA, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA
|
NHLBI, NINDS
|
The NIH provided input via CMS and CDC on the development and implementation of the Million Hearts Initiative.
|
|
Modeling Infectious Disease Agent Systems (MIDAS) Committee for Methicillin-Resistant Staph
|
Research Initiative
|
AHRQ, CDC
|
NIGMS
|
Consultations and committee participation with MIDAS continues on a study of Methicillin-resistant Staphylococcus aureus (MRSA), a virulent bacterial staph infection that is highly resistant to some antibiotics, and spread among health care settings in Orange County California.
|
|
Models of Infectious Disease Agent Study (MIDAS)
|
Research Initiative
|
CDC
|
NIGMS, FIC
|
Models of Infectious Disease Agent Study (MIDAS) is a collaboration of research and informatics groups to develop computational models of the interactions between infectious agents and their hosts, disease spread, prediction systems and response strategies. The models will be useful to policymakers, public health workers and other researchers who want to better understand and respond to emerging infectious diseases. If a disease outbreak occurs, the MIDAS network may be called upon to develop specific models to aid public officials in their decision-making processes.
|
|
Moving Towards a Coordinated HHS Approach to Sustainability: Strategies for Sustainable Change
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, SAMHSA
|
NHLBI
|
The purpose of the collaborative activity was to plan a workshop with the HHS Office of Women''s Health entitled "Moving Towards a Coordinated HHS Approach to Sustainability: Strategies for Sustainable Change."
|
|
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA
|
NHLBI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR
|
The MATES provides a forum for federal agencies involved in tissue science and engineering to stay informed of each other''s activities and coordinate research efforts.
|